Back to All NewsAllergan Completes Vitae Tender Offer
Posted By American Med Spa Association, Tuesday, November 1, 2016
Share
Allergan completed their tender offer to purchase all outstanding shares of Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company.
A tender offer occurs when an acquiring company offers to buy another company's stock from shareholders at a specified price. The next step is a merger. Allergan offered to purchase all outstanding shares of Vitae for $21.00 per share, in cash, for a total transaction value of approximately $639 million.
Read More >>
A tender offer occurs when an acquiring company offers to buy another company's stock from shareholders at a specified price. The next step is a merger. Allergan offered to purchase all outstanding shares of Vitae for $21.00 per share, in cash, for a total transaction value of approximately $639 million.
Read More >>
